SCHEMBL26985478

SCHEMBL26985478

CCCCC(CC)C(=O)Oc1ccc(C)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.61
GAA P10253 1/20 0.61
XBP1 P17861 1/20 0.61
ATM Q13315 1/20 0.61
NPSR1 Q6W5P4 1/20 0.61
CA2 P00918 6/20 0.53
CA1 P00915 4/20 0.53
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
PTGES O14684 1/20 0.45
ALOX5 P09917 1/20 0.45
PPARG P37231 1/20 0.45
PPARA Q07869 1/20 0.45
LMNA P02545 2/20 0.44
MAPK1 P28482 2/20 0.44
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27004796 0.95 NPSR1 (0.56) L3MBTL1GAAXBP1ATMNPSR1
SCHEMBL27314199 0.88 L3MBTL1 (0.65) L3MBTL1GAAXBP1ATMNPSR1
SCHEMBL2294906 0.86 L3MBTL1 (0.59) L3MBTL1GAAXBP1ATMNPSR1
SCHEMBL28282719 0.85 L3MBTL1 (0.59) L3MBTL1GAAXBP1ATMNPSR1
Ammonia Solution, Strong SCHEMBL10503063 0.84 L3MBTL1 (0.58) L3MBTL1GAAXBP1ATMNPSR1
SCHEMBL8208789 0.84 L3MBTL1 (0.58) L3MBTL1GAAXBP1ATMNPSR1
P-Xylene SCHEMBL17456358 0.84 CA2 (0.56) L3MBTL1GAAXBP1ATMNPSR1
SCHEMBL18466207 0.84 GAA (0.57) L3MBTL1GAAXBP1ATMNPSR1
SCHEMBL20519927 0.84 L3MBTL1 (0.57) L3MBTL1GAAXBP1ATMNPSR1
SCHEMBL26564909 0.83 HDAC1 (0.55) L3MBTL1GAAXBP1ATMNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260001831-A1 COPPER MEDIATED CONVERSION OF ARENES AND ALKENES TO ESTERS, ALCOHOLS, AND ALDEHYDE PRODUCTS SCHINSKI WILLIAM L (US) 2026-01-01 US disclosed
WO-2024011156-A9 COPPER MEDIATED CONVERSION OF ARENES AND ALKENES TO ESTERS, ALCOHOLS, AND ALDEHYDE PRODUCTS UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2024-10-17 WO disclosed
WO-2024011156-A2 COPPER MEDIATED CONVERSION OF ARENES AND ALKENES TO ESTERS, ALCOHOLS, AND ALDEHYDE PRODUCTS UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2024-01-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260001831-A1 COPPER MEDIATED CONVERSION OF ARENES AND ALKENES TO ESTERS, ALCOHOLS, AND ALDEHYDE PRODUCTS AOC3, AOC2, ADH1A L3MBTL1 4765/4885GAA 1870/4885XBP1 1656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.